'Intermittent therapy' diaporamas de présentation

Selected Controversies in Antiretroviral Therapy

Selected Controversies in Antiretroviral Therapy. Joel E. Gallant, MD, MPH Johns Hopkins University School of Medicine. When to Start Therapy?. Will We Return to Earlier Therapy?. Availability of more potent, easier, and less toxic regimens. 1996: ddI + d4T + SQV

731 views • 60 slides

807 views • 53 slides

Jeffrey Meyerhardt, MD, MPH Dana-Farber Cancer Institute Boston, MA

532 views • 43 slides

Trials and evidence in relation to health policy: The case of tuberculosis in Nepal and India

Trials and evidence in relation to health policy: The case of tuberculosis in Nepal and India. Ian Harper. Rifampicin. Overview of presentation. Rifampicin, and its history in TB control Regulation DOTS Procurement for NTPs Relations between the private sector and NTP (India and Nepal)

193 views • 19 slides